Welcome Guest
Sign In
Register
Products
Popular Categories
Antibody Search
ELISA Kit Search
Biomolecules
Flow Cytometers
Thermal Cyclers
Microscopes
Transfection Reagents
Featured Products
New Products
Research Areas
ELISA
Western Blot
3D Cell Culture
Digital PCR
Quantitative PCR
Cell and Gene Therapy
In Vivo Models
Resources
eBooks
Bench Tips
Tech Insights
Editorial Articles
News
Product Reviews
Future Lab
White Papers
Infographics
Events
Promotions
Multimedia
Biocompare Webinars
Technologies Transforming Precision Medicine
Immunotherapy
Reproducibility
Transformative Technologies
Podcasts
Bench Tip Videos
All Videos and Webinars
Life Science Webinars
Write a Review
Antibodies
Kits/Reagents
Equipment
Services
Register
Sign In
Biocompare
Products
Cloning and Expression
Library Construction
cDNA Synthesis
RNA
RNA
HDAC2 shRNA Plasmid (h)
Supplier Images
HDAC2 shRNA Plasmid (h)
HDAC2 shRNA Plasmid (h) from Santa Cruz Biotechnology, Inc.
Be the first to write a review!
Citations:
(34)
Supplier Page
Supplier Page from
Santa Cruz Biotechnology, Inc. for
HDAC2 shRNA Plasmid (h)
Product Specs
Company Info
Citations
Reviews
Product Specs
Item
HDAC2 shRNA Plasmid (h)
Company
Santa Cruz Biotechnology, Inc.
Price
$592.00
Supplier Page
View Company Product Page
Catalog Number
sc-29345-SH
Quantity
20 µg
RNA Type
shRNA Clones
Vector Type (Standardized)
Lentiviral
Type
shRNA Plasmid
Species
human
NCBI Full Gene Name
histone deacetylase 2
NCBI Gene Aliases
HD2, KDAC2, RPD3, YAF1
Add to Compare List
Santa Cruz Biotechnology, Inc.
10410 Finnell Street
Dallas
,
Texas
75220
United States
Phone
: 1-800-457-3801
831-457-3801
Company Profile
Website:
http://www.scbt.com/
Citations (34)
(1)
Interaction of HDAC2 with SARS-CoV-2 NSP5 and IRF3 Is Not Required for NSP5-Mediated Inhibition of Type I Interferon Signaling Pathway
Microbiology spectrum
October 26, 2022
Naik NG, Lee SC, Veronese BHS, Ma Z, Toth Z.
(2)
HDAC2- and EZH2-Mediated Histone Modifications Induce PDK1 Expression through miR-148a Downregulation in Breast Cancer Progression and Adriamycin Resistance
Cancers
July 23, 2022
Xie Y, Shi Z, Qian Y, Jiang C, Liu W, Liu B, Jiang B.
(3)
Class I HDAC overexpression promotes temozolomide resistance in glioma cells by regulating RAD18 expression
Cell death & disease
April 1, 2022
Hanisch D, Krumm A, Diehl T, Stork CM, Dejung M, Butter F, Kim E, Brenner W, Fritz G, Hofmann TG,
et al
.
(4)
Histone deacetylase inhibitors inhibit cervical cancer growth through Parkin acetylation-mediated mitophagy
Acta pharmaceutica Sinica. B
February 1, 2022
Sun X, Shu Y, Ye G, Wu C, Xu M, Gao R, Huang D, Zhang J.
(5)
NF-κB-dependent repression of Sox18 transcription factor requires the epigenetic regulators histone deacetylases 1 and 2 in acute lung injury
Frontiers in physiology
January 1, 2022
Zemskov EA, Gross CM, Aggarwal S, Zemskova MA, Wu X, Gu C, Wang T, Tang H, Black SM.
(6)
HDAC1 and 2 regulate endothelial VCAM-1 expression and atherogenesis by suppressing methylation of the GATA6 promoter
Theranostics
January 1, 2021
Hu C, Peng K, Wu Q, Wang Y, Fan X, Zhang DM, Passerini AG, Sun C.
(7)
Histone deacetylase 6 inhibitor tubastatin A attenuates angiotensin II-induced hypertension by preventing cystathionine γ-lyase protein degradation
Pharmacological research
August 1, 2019
Chi Z, Byeon HE, Seo E, Nguyen QT, Lee W, Jeong Y, Choi J, Pandey D, Berkowitz DE, Kim JH,
et al
.
(8)
miR-31 shuttled by halofuginone-induced exosomes suppresses MFC-7 cell proliferation by modulating the HDAC2/cell cycle signaling axis
Journal of cellular physiology
August 1, 2019
Xia X, Wang X, Zhang S, Zheng Y, Wang L, Xu Y, Hang B, Sun Y, Lei L, Bai Y,
et al
.
(9)
Targeting the Difficult-to-Drug CD71 and MYCN with Gambogic Acid and Vorinostat in a Class of Neuroblastomas
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
January 1, 2019
Bishayee K, Habib K, Sadra A, Huh SO.
(10)
Enhanced osteopontin splicing regulated by RUNX2 is HDAC-dependent and induces invasive phenotypes in NSCLC cells
Cancer cell international
January 1, 2019
Huang J, Chang S, Lu Y, Wang J, Si Y, Zhang L, Cheng S, Jiang WG.
(11)
Altered modulation of lamin A/C-HDAC2 interaction and p21 expression during oxidative stress response in HGPS
Aging cell
October 1, 2018
Mattioli E, Andrenacci D, Garofalo C, Prencipe S, Scotlandi K, Remondini D, Gentilini D, Di Blasio AM, Valente S, Scarano E,
et al
.
(12)
EGF-Mediated Overexpression of Myc Attenuates miR-26b by Recruiting HDAC3 to Induce Epithelial-Mesenchymal Transition of Lens Epithelial Cells
BioMed research international
January 1, 2018
Dong N, Xu B, Xu J.
(13)
Importance of TFEB acetylation in control of its transcriptional activity and lysosomal function in response to histone deacetylase inhibitors
Autophagy
January 1, 2018
Zhang J, Wang J, Zhou Z, Park JE, Wang L, Wu S, Sun X, Lu L, Wang T, Lin Q,
et al
.
(14)
Epigenetic regulation of interleukin-8 expression by class I HDAC and CBP in ovarian cancer cells
Oncotarget
September 19, 2017
Gatla HR, Zou Y, Uddin MM, Vancurova I.
(15)
HDAC2 regulates cell proliferation, cell cycle progression and cell apoptosis in esophageal squamous cell carcinoma EC9706 cells
Oncology letters
January 1, 2017
Li S, Wang F, Qu Y, Chen X, Gao M, Yang J, Zhang D, Zhang N, Li W, Liu H.
(16)
Down-Regulation of Ca(2+)-Activated K⁺ Channel K(Ca)1.1 in Human Breast Cancer MDA-MB-453 Cells Treated with Vitamin D Receptor Agonists
International journal of molecular sciences
December 11, 2016
Khatun A, Fujimoto M, Kito H, Niwa S, Suzuki T, Ohya S.
(17)
Class I HDACs specifically regulate E-cadherin expression in human renal epithelial cells
Journal of cellular and molecular medicine
December 1, 2016
Choi SY, Kee HJ, Kurz T, Hansen FK, Ryu Y, Kim GR, Lin MQ, Jin L, Piao ZH, Jeong MH.
(18)
Downregulation of the Ca(2+)-activated K(+) channel KC a3.1 by histone deacetylase inhibition in human breast cancer cells
Pharmacology research & perspectives
April 1, 2016
Ohya S, Kanatsuka S, Hatano N, Kito H, Matsui A, Fujimoto M, Matsuba S, Niwa S, Zhan P, Suzuki T,
et al
.
(19)
Trichostatin A Inhibits Epithelial Mesenchymal Transition Induced by TGF-β1 in Airway Epithelium
PloS one
January 1, 2016
Park IH, Kang JH, Shin JM, Lee HM.
(20)
Selective inhibition of histone deacetylase 2 induces p53-dependent survivin downregulation through MDM2 proteasomal degradation
Oncotarget
September 22, 2015
Seo SK, Hwang CS, Choe TB, Hong SI, Yi JY, Hwang SG, Lee HG, Oh ST, Lee YH, Park IC.
Page
<<
<
1
2
>
>>
Reviews
Be the First to Write a Review!
HDAC2 shRNA Plasmid (h) from Santa Cruz Biotechnology, Inc.
Supplier Page
View Company Product Page
$592.00
Product Specs
Company Info
Citations
Reviews
Back To Top